Thermo Fisher Scientific (TMO) Stock Forecast & Price Target

$677.71 +2.71 (+0.40%)

Closing price 03:58 PM Eastern

Extended Trading

$672.50 -5.22 (-0.77%)

As of 07:59 PM Eastern

Compare

Thermo Fisher Scientific - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 26 Analyst Ratings

Sell
2

Hold
4

Buy
20

Based on 26 Wall Street analysts who have issued ratings for Thermo Fisher Scientific in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 26 analysts, 2 have given a sell rating, 4 have given a hold rating, 18 have given a buy rating, and 2 have given a strong buy rating for TMO.

Consensus Price Target

$628.78
-7.22% Downside

According to the 26 analysts' twelve-month price targets for Thermo Fisher Scientific, the average price target is $628.78. The highest price target for TMO is $750.00, while the lowest price target for TMO is $520.00. The average price target represents a forecasted downside of -7.22% from the current price of $677.71.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for TMO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Thermo Fisher Scientific and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TMO Analyst Ratings Over Time

Type	Current Forecast 9/28/25 to 9/28/26	1 Month Ago 8/29/25 to 8/29/26	3 Months Ago 6/30/25 to 6/30/26	1 Year Ago 9/28/24 to 9/28/25
Strong Buy	2 Strong Buy rating(s)	1 Strong Buy rating(s)	2 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	18 Buy rating(s)	16 Buy rating(s)	18 Buy rating(s)	16 Buy rating(s)
Hold	4 Hold rating(s)	6 Hold rating(s)	6 Hold rating(s)	5 Hold rating(s)
Sell	2 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$628.78	$619.41	$605.09	$588.35
Forecasted Upside	-7.22% Downside	-0.40% Downside	20.93% Upside	26.75% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

TMO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

TMO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Thermo Fisher Scientific Stock vs. The Competition

Type	Thermo Fisher Scientific	Healthcare Companies	Broader Market
Consensus Rating Score	2.77	2.31	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	-7.41% Downside	775.98% Upside	19.88% Upside
News Sentiment Rating	Positive News See Recent TMO News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
9/25/2026	Deutsche Bank Aktiengesellschaft 2 of 5 stars		Reiterated Rating	Buy	$720.00	+8.08%
9/9/2026	Piper Sandler 2 of 5 stars	David Westenberg 4 of 5 stars	Initiated Coverage	Hold ➝ Overweight
9/9/2026	Scotiabank 4 of 5 stars		Initiated Coverage	Outperform
9/9/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Market Perform
9/9/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Couillard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Overweight ➝ Underweight
9/9/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Buy ➝ Underperform
9/8/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Doug Schenkel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$540.00 ➝ $730.00	+20.97%
9/3/2026	CLSA Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Luo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Outperform	C$748.00
9/1/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sidharth Sahoo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/28/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold (C) ➝ Hold (C+)
Get the Latest News and Ratings for TMO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Thermo Fisher Scientific and its competitors with MarketBeat's FREE daily newsletter.
8/5/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Arias Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$650.00	+14.50%
7/24/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kallum Titchmarsh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$620.00 ➝ $650.00	+14.57%
7/24/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Leonard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Sector Perform	$490.00 ➝ $580.00	+2.72%
7/24/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Luke Sergott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$625.00 ➝ $650.00	+13.35%
7/23/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy	$630.00	+9.86%
7/6/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$570.00	+11.06%
6/26/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eve Burstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Market Perform	$520.00	+2.73%
6/2/2026	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Polark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Outperform	$535.00	+8.48%
5/26/2026	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Overweight
4/24/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Catherine Ramsey Schulte Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$653.00 ➝ $639.00	+36.85%
3/27/2026	DZ Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Buy	$610.00	+24.85%
1/30/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Brennan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$696.00 ➝ $683.00	+18.43%
12/9/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Evie Koslosky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy	$685.00	+20.63%
10/29/2025	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Toung Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$580.00 ➝ $610.00	+6.91%
10/22/2025	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Puneet Souda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$545.00 ➝ $580.00	+2.04%
10/9/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Casey Woodring Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$600.00 ➝ $650.00	+21.11%
10/8/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$580.00	+7.50%
8/18/2025	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Larew Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Outperform
7/24/2025	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Cooper Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$525.00 ➝ $535.00	+11.59%
12/13/2024	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$675.00 ➝ $660.00	+26.05%
10/22/2024	Bernstein Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Market Perform	$565.00 ➝ $625.00	+6.30%
10/1/2024	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	J. Johnson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Overweight	$680.00	+9.93%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 08:02 PM ET.

Should I Buy Thermo Fisher Scientific Stock? TMO Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, September 28, 2026. Please send any questions or comments about these Thermo Fisher Scientific pros and cons to contact@marketbeat.com.

Thermo Fisher Scientific
Bull Case

Here are some ways that investors could benefit from investing in Thermo Fisher Scientific Inc.:

Thermo Fisher Scientific Inc. recently reported strong second-quarter results on July 23, 2026, beating analyst expectations with earnings per share of $6.03 compared to the consensus estimate of $5.71, while revenue of $11.99 billion also exceeded the $11.71 billion forecast, demonstrating robust operational performance and demand for its life sciences solutions.
The company has established a dominant position in high-growth sectors such as gene-transfer technologies and bioreactors, which are projected to expand significantly through 2035 and 2036, providing a long-term tailwind for its instruments, reagents, and manufacturing solutions as gene and cell therapies advance.
Thermo Fisher Scientific Inc. is actively expanding its product portfolio with recent launches like the Gibco CHO-K1 Catalog Panel, a cGMP-ready media offering for biologics developers, which enhances its value proposition for scalable cell culture performance and productivity in the biopharmaceutical market.
With the current stock price at $677.71, the company is trading near its 52-week high of $682.98, reflecting strong investor confidence and a significant recovery from its 52-week low of $435.27, indicating a positive momentum in the market for this medical research leader.
Wall Street analysts maintain a "Moderate Buy" consensus rating for the stock, with an average price target of $624.64, and recent research from Deutsche Bank describes the company's building blocks for growth through 2028 as "fundamentally sound," suggesting continued institutional support.

Thermo Fisher Scientific
Bear Case

Investors should be bearish about investing in Thermo Fisher Scientific Inc. for these reasons:

Despite the strong recent performance, the current stock price of $677.71 is significantly higher than the average analyst price target of $624.64, suggesting that the stock may be overvalued relative to Wall Street's consensus fair value estimate.
Company insiders have engaged in substantial selling activity recently, with CEO Marc Casper and other executives selling tens of thousands of shares in August 2026, which can signal a lack of confidence in the stock's short-term upside or a desire to diversify personal holdings.
The company's P/E ratio stands at 36.46, which is relatively high compared to many industrial and healthcare peers, indicating that investors are paying a premium for growth that may not be immediately reflected in current earnings, increasing the risk if growth slows.
Thermo Fisher Scientific Inc. faces intense competition in the life sciences tools and services industry, with rivals like Bio-Rad, Beckman Coulter, and Sartorius also expanding in key areas such as cell isolation and bioreactors, which could pressure margins and market share.
The stock has experienced volatility, including a gap down of $41.33 on April 23, 2026, and recent pre-market slips, suggesting that the market remains cautious about the company's ability to sustain its rapid growth trajectory amid broader economic uncertainties.

TMO Forecast - Frequently Asked Questions

According to the research reports of 26 Wall Street equities research analysts, the average twelve-month stock price forecast for Thermo Fisher Scientific is $628.78, with a high forecast of $750.00 and a low forecast of $520.00.

26 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Thermo Fisher Scientific in the last twelve months. There are currently 2 sell ratings, 4 hold ratings, 18 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TMO shares.

According to analysts, Thermo Fisher Scientific's stock has a predicted downside of -7.22% based on their 12-month stock forecasts.

Over the previous 90 days, Thermo Fisher Scientific's stock had 4 upgrades and 4 downgrades by analysts.

Thermo Fisher Scientific has been rated by research analysts at Barclays, BMO Capital Markets, Citigroup, CLSA, Deutsche Bank Aktiengesellschaft, Evercore, HSBC, Jefferies Financial Group, Morgan Stanley, Piper Sandler, Royal Bank Of Canada, Scotiabank, Stifel Nicolaus, UBS Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like Thermo Fisher Scientific more than other "healthcare" companies. The consensus rating for Thermo Fisher Scientific is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how TMO compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Thermo Fisher Scientific Recommendations

MarketBeat monitors more than a dozen sources for Thermo Fisher Scientific analyst ratings, with the most recent rating issued on 9/25/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thermo Fisher Scientific (TMO) Stock Forecast & Price Target

Thermo Fisher Scientific - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

TMO Analyst Ratings Over Time

TMO Analyst Recommendations By Month

TMO Price Targets by Month

Thermo Fisher Scientific Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Thermo Fisher Scientific Stock? TMO Pros and Cons Explained

Thermo Fisher Scientific
Bull Case

Thermo Fisher Scientific
Bear Case

TMO Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Thermo Fisher Scientific Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Thermo Fisher Scientific (TMO) Stock Forecast & Price Target

Thermo Fisher Scientific - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

TMO Analyst Ratings Over Time

TMO Analyst Recommendations By Month

TMO Price Targets by Month

Thermo Fisher Scientific Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Thermo Fisher Scientific Stock? TMO Pros and Cons Explained

Thermo Fisher Scientific Bull Case

Thermo Fisher Scientific Bear Case

TMO Forecast - Frequently Asked Questions

What is Thermo Fisher Scientific's forecast for 2026?

Should I buy or sell Thermo Fisher Scientific stock right now?

Does Thermo Fisher Scientific's stock price have much downside?

Has Thermo Fisher Scientific been upgraded or downgraded by Wall Street analysts recently?

What analysts cover Thermo Fisher Scientific?

Do Wall Street analysts like Thermo Fisher Scientific more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Thermo Fisher Scientific Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Thermo Fisher Scientific
Bull Case

Thermo Fisher Scientific
Bear Case